Paying users zone. Data is covered by 
.
Get to Bristol-Myers Squibb Co. for $15.99, or
get to whole website for at least 3 months from $49.99.
Income Statement
Difficulty: Beginner
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Bristol-Myers Squibb Co., Consolidated Income Statement
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net product sales | |
|
|
|
|
||||||
| Alliance and other revenues | |
|
|
|
|
||||||
| Revenues | |
|
|
|
|
||||||
| Cost of products sold | |
|
|
|
|
||||||
| Gross margin | |
|
|
|
|
||||||
| Marketing, selling and administrative | |
|
|
|
|
||||||
| Research and development | |
|
|
|
|
||||||
| Operating income | |
|
|
|
|
||||||
| Interest expense | |
|
|
|
|
||||||
| Interest income | |
|
|
|
|
||||||
| Provision for restructuring | |
|
|
|
|
||||||
| Litigation and other settlements | |
|
|
|
|
||||||
| Equity in net income of affiliates | |
|
|
|
|
||||||
| Divestiture gains | |
|
|
|
|
||||||
| Royalties and licensing income | |
|
|
|
|
||||||
| Transition and other service fees | |
|
|
|
|
||||||
| Other alliance and licensing income | |
|
|
|
|
||||||
| Pension charges | |
|
|
|
|
||||||
| Intangible asset impairment | |
|
|
|
|
||||||
| Equity investment impairment | |
|
|
|
|
||||||
| Written option adjustment | |
|
|
|
|
||||||
| Loss on debt redemption | |
|
|
|
|
||||||
| Other | |
|
|
|
|
||||||
| Other income (expense), net | |
|
|
|
|
||||||
| Earnings before income taxes | |
|
|
|
|
||||||
| Provision for income taxes | |
|
|
|
|
||||||
| Net earnings | |
|
|
|
|
||||||
| Noncontrolling interest | |
|
|
|
|
||||||
| Net earnings attributable to BMS | |
|
|
|
|
Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14).
| Item | Description | The company |
|---|---|---|
| Revenues | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | Bristol-Myers Squibb Co.'s revenues increased from 2015 to 2016 and from 2016 to 2017. |
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Bristol-Myers Squibb Co.'s operating income increased from 2015 to 2016 but then slightly declined from 2016 to 2017. |
| Earnings before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Bristol-Myers Squibb Co.'s earnings before income taxes increased from 2015 to 2016 but then slightly declined from 2016 to 2017. |
| Net earnings attributable to BMS | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Bristol-Myers Squibb Co.'s net earnings attributable to BMS increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
